Insulet | PODD - Cash And Equivalent

Stock Price
251.24
Daily Change
0.02 0.01%
Monthly
-11.38%
Yearly
-11.75%
Q1 Forecast
247.93

Insulet reported $757.4M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Abbott USD 7.51B 560M Sep/2025
Align Technology USD 1B 103.43M Sep/2025
AtriCure USD 147.86M 30.07M Sep/2025
Avanos Medical USD 70.5M 19.8M Sep/2025
Baxter International USD 1.73B 40M Sep/2025
Becton, Dickinson and Co. USD 641M 94M Sep/2025
Boston Scientific USD 1.28B 741M Sep/2025
Cardinal Health USD 4.59B 719M Sep/2025
Cooper Companies USD 124.9M 13.3M Jun/2025
Dexcom USD 1.84B 676.7M Sep/2025
Edwards Lifesciences USD 2.69B 587.2M Sep/2025
Eli Lilly USD 9.79B 6.42B Sep/2025
Globus Medical USD 229.45M 231.82M Jun/2025
ICU Medical USD 300.02M 10.32M Jun/2025
Insulet USD 757.4M 364.2M Sep/2025
Integra LifeSciences USD 232.19M 14.27M Sep/2025
J&J USD 18.23B 10.35B Sep/2025
Masimo USD 312.3M 162.7M Sep/2025
Medtronic USD 1.28B 9M Sep/2025
Merit Medical Systems USD 392.46M 50.64M Sep/2025
Roche Holding CHF 7.55B 579M Jun/2025
Solventum Corp USD 1.64B 1.15B Sep/2025
Stryker USD 3.26B 881M Sep/2025
Tandem Diabetes Care USD 91.95M 27.83M Sep/2025
Teleflex USD 354M 100.3M Sep/2025
West Pharmaceutical Services USD 628.5M 118.8M Sep/2025
Zimmer Biomet Holdings USD 1.29B 735.8M Sep/2025